Issue 2/2009

BioBran-augmented maturation of human monocyte-derived dendritic cells (89 — 95)

D. CHOLUJOVA, J. JAKUBIKOVA, J. SEDLAK

DOI: 10.4149/neo_2009_02_89

IL-17 family cytokines in neutrophils of patients with oral epithelial squamous cell carcinoma (96 — 100)

M. GARLEY, E. JABLONSKA, S. Z. GRABOWSKA, L. PIOTROWSKI

DOI: 10.4149/neo_2009_02_96

Frequency of the three most common polymorphisms in the MDR1 gene in Slovak population (101 — 107)

T. KRIVULCIK, J. SEDLAK, Z. BARTOSOVA

DOI: 10.4149/neo_2009_02_101

β-arrestin2 inhibits opioid-induced breast cancer cell death through Akt and caspase-8 pathways (108 — 113)

M. ZHAO, G. ZHOU, Y. ZHANG, T. CHEN, X. SUN, C. STUART, G. HANLEY, J. LI, J. ZHANG, D. YIN

DOI: 10.4149/neo_2009_02_108

The p53 codon 72 polymorphism and susceptibility to colorectal cancer in Korean patients (114 — 118)

Z. CAO, J. H. SONG, Y. K. PARK, E. J. MAENG, S. W. NAM, J. Y. LEE, W. S. PARK

DOI: 10.4149/neo_2009_02_114

Overexpression of Wnt-2 in colorectal cancers (119 — 123)

J. K. PARK, J. H. SONG, T. C. HE, S. W. NAM, J. Y. LEE, W. S. PARK

DOI: 10.4149/neo_2009_02_119

Side effects of anastrozole in the experimental pre-menopausal mammary carcinogenesis (124 — 129)

V. SADLONOVA, P. KUBATKA, K. KAJO, D. OSTATNIKOVA, G. NOSALOVA, K. ADAMICOVA, J. SADLONOVA

DOI: 10.4149/neo_2009_02_124

Expression pattern of anti-apoptotic protein survivin in dysplastic nevi (130 — 135)

M. ADAMKOV, L. LAUKO, S. BALENTOVA, J. PEC, M. PEC, J. RAJCANI

DOI: 10.4149/neo_2009_02_130

Mutational analysis of JAK1 gene in human hepatocellular carcinoma (136 — 140)

H. J. XIE, H. J. BAE, J. H. NOH, J. W. EUN, J. K. KIM, K. H. JUNG, J. C. RYU, Y. M. AHN, S. Y. KIM, S. H. LEE, N. J. YOO, J. Y. LEE, W. S. PARK, S. W. NAM

DOI: 10.4149/neo_2009_02_136

Combination of mRNA and protein microarray analysis in complex cell profiling (141 — 149)

P. SIMARA, I. KOUTNA, S. STEJSKAL, P. KRONTORAD, Z. RUCKA, M. PETERKOVA, M. KOZUBEK

DOI: 10.4149/neo_2009_02_141

Anal cancer chemoirradiation with curative intent – a single institution experience (150 — 155)

I. OBLAK, P. PETRIC, F. ANDERLUH, V. VELENIK, R. HUDEJ, A. P. FRAS

DOI: 10.4149/neo_2009_02_150

Post-therapeutical changes in the brain: novel trends in imaging and their infuence on external beam radiotherapy (156 — 162)

M. CHORVATH, E. BOLJESIKOVA, L. PRUZINCOVA, V. PROCKA, B. RYCHLY, M. NOVOTNY, P. KALINA, V. BELAN, I. MAKAIOVA, J. STENO

DOI: 10.4149/neo_2009_02_156

High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma – a radiobiological study (163 — 168)

J. PETERA, P. MATULA, P. PALUSKA, I. SIRAK, Z. MACINGOVA, L. KASAOVA, T. FRGALA, M. HODEK, M. VOSMIK

DOI: 10.4149/neo_2009_02_163

Evaluation of centrosome abnormalities and p53 inactivation in chemical induced hepatocellular carcinogenesis (169 — 176)

Y. CHEN, Q. KONG

DOI: 10.4149/neo_2009_02_169